Item 2.02 Results of Operations and Financial Condition.
On
On
The information in this report, including the exhibit hereto, is being furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended. The information contained herein and in the accompanying exhibit shall
not be incorporated by reference into any filing with the
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description 99.1 Press release titled "Nektar Therapeutics Reports Second Quarter 2020 Financial Results" issued byNektar Therapeutics onAugust 6, 2020 . 1
© Edgar Online, source